InMed Pharmaceuticals Inc
NASDAQ:INM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
InMed Pharmaceuticals Inc
NASDAQ:INM
|
CA |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
GlobalData PLC
LSE:DATA
|
UK |
Intrinsic Value
The intrinsic value for
InMed Pharmaceuticals Inc (INM) under the Base Case is 0.94 USD.
Compared with the current market price of 1.35 USD, the stock appears
Overvalued by 30% .
Do our valuations actually work? See backtest results .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for InMed Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
InMed Pharmaceuticals Inc
Earnings Waterfall
InMed Pharmaceuticals Inc
The intrinsic value for
InMed Pharmaceuticals Inc (INM) under the Base Case is 0.94 USD.
Compared with the current market price of 1.35 USD, the stock appears Overvalued by 30% .